Clinuvel Pharmaceuticals Ltd. financial statements, including revenue, expenses, profit, and loss
The total revenue of CLVLY for the last semiannual is 21.05 M USD, and it's 36.38% lower compared to the previous semiannual. The net income of H1 24 is 7.14 M USD.